Creative Medical Technology Holdings, Inc.
As of Oct 22, 2026, Creative Medical Technology Holdings is in Stage 4, the downtrend phase, now in its first week (since Oct 22, 2026). It closed at $0.77, 86.2% below its 52-week high and below its 200-day average, which is falling.
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and or… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is CELZ early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
CELZ among Biotechnology452nd of 591 by relative strength
All 591 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | GTBP | Stage 2 · wk 7 | 99 | −22.3% |
| 2 | IOVA | Stage 2 · wk 18 | 99 | +38.8% |
| 3 | SLS | Stage 3 · wk 4 | 99 | −1.5% |
| 4 | MRNA | Stage 2 · wk 17 | 99 | +11.3% |
| 5 | TWST | Stage 2 · wk 39 | 99 | −14.5% |
| 6 | KOD | Stage 2 · wk 4 | 99 | +172.1% |
| 7 | ERAS | Stage 3 · wk 5 | 99 | +0.7% |
| 8 | CLYM | Stage 3 · wk 3 | 99 | −15.8% |
| …452 | CELZ | Stage 4 · wk 1 | 12 | −20.5% |
Creative Medical Technology Holdings: quick answers
What stage is Creative Medical Technology Holdings in?
As of Oct 22, 2026, Creative Medical Technology Holdings (CELZ) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 22, 2026 and is in its first week there. What the four stages mean
Is Creative Medical Technology Holdings in an uptrend?
No. Creative Medical Technology Holdings is in a Stage 4 downtrend. It trades 52.2% below its 200-day average, which is falling.
How far is Creative Medical Technology Holdings from its 52-week high?
Creative Medical Technology Holdings closed at $0.77 on Oct 22, 2026, 86.2% below its 52-week high of $5.59. Its 52-week low is $0.65.
How has Creative Medical Technology Holdings performed over the past year?
As of Oct 22, 2026, Creative Medical Technology Holdings is down 79.1% over the past year and down 60.7% so far in 2026.
Which sector and industry is Creative Medical Technology Holdings in?
Creative Medical Technology Holdings is in the Biotechnology industry, part of the Health Care sector.
About this companyHealth Care· Biotechnology
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, a platform to treat infertility as a result of premature ovarian failure; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.